What is Discovery and development of TRPV1 antagonists

What is Discovery and development of TRPV1 antagonists

Transient Receptor Potential Vanilloid 1 (TRPV1)Подробнее

Transient Receptor Potential Vanilloid 1 (TRPV1)

PILA PHARMA x LSX Nordic 11/10/2023 (#TRPV1 antagonist treatment for #obesity & #diabetes) New data!Подробнее

PILA PHARMA x LSX Nordic 11/10/2023 (#TRPV1 antagonist treatment for #obesity & #diabetes) New data!

A conversation on how to treat possibly #Diabetes & #Obesity with #TRPV1-antagonistsПодробнее

A conversation on how to treat possibly #Diabetes & #Obesity with #TRPV1-antagonists

New Positive Phase 2 Data - on our TRPV1 antagonist, ACD440, against peripheral neuropathic painПодробнее

New Positive Phase 2 Data - on our TRPV1 antagonist, ACD440, against peripheral neuropathic pain

Women's Health and Cannabis, CoIIN WebinarПодробнее

Women's Health and Cannabis, CoIIN Webinar

Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonistsПодробнее

Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonists